tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gavin Clark-Gartner, 37 are a BUY (92.5%), 3 are a HOLD (7.5%).
Analyst Gavin Clark-Gartner, currently employed at EVERCORE, carries an average stock price target met ratio of 75.55% that have a potential upside of 36.73% achieved within 111 days.
Gavin Clark-Gartner’s has documented 79 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 10-Aug-2026.
Analyst best performing recommendations are on ATXS (ASTRIA THERAPEUTICS).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 7/17/2023. The price target of $537 was fulfilled within 4 days with a profit of $52.57 (10.85%) receiving and performance score of 27.13.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Sep-2025
$303
$38.04 (14.36%)
$298
Buy Since 08-Dec-2021
$300
$35.04 (13.22%)
$295
Buy Since 23-Jan-2023
$260
$-4.96 (-1.87%)
$235
Buy Since 06-Feb-2020
$288
$23.04 (8.70%)
$261
Buy Since 23-Jan-2024
$285
$20.04 (7.56%)
$265
Which stock is Gavin Clark-Gartner is most bullish on?
Which stock is Gavin Clark-Gartner is most reserved on?
What Year was the first public recommendation made by Gavin Clark-Gartner?
